Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ARE 
Alexandria Real Estate Equities Inc (ARE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: ARE (1-star) is a SELL. SELL since 4 days. Profits (-5.78%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $98.83
1 Year Target Price $98.83
| 3 | Strong Buy |
| 1 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -28.33% | Avg. Invested days 22 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.72B USD | Price to earnings Ratio - | 1Y Target Price 98.83 |
Price to earnings Ratio - | 1Y Target Price 98.83 | ||
Volume (30-day avg) 13 | Beta 1.25 | 52 Weeks Range 66.16 - 118.73 | Updated Date 08/15/2025 |
52 Weeks Range 66.16 - 118.73 | Updated Date 08/15/2025 | ||
Dividends yield (FY) 7.02% | Basic EPS (TTM) -0.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-21 | When After Market | Estimate 0.63 | Actual 0.48 |
Profitability
Profit Margin -0.33% | Operating Margin (TTM) 20.36% |
Management Effectiveness
Return on Assets (TTM) 1.2% | Return on Equity (TTM) 0.78% |
Valuation
Trailing PE - | Forward PE 16.69 | Enterprise Value 25857398913 | Price to Sales(TTM) 4.11 |
Enterprise Value 25857398913 | Price to Sales(TTM) 4.11 | ||
Enterprise Value to Revenue 8.56 | Enterprise Value to EBITDA 15.29 | Shares Outstanding 170720992 | Shares Floating 154077020 |
Shares Outstanding 170720992 | Shares Floating 154077020 | ||
Percent Insiders 0.99 | Percent Institutions 96.28 |
Upturn AI SWOT
Alexandria Real Estate Equities Inc
Company Overview
History and Background
Alexandria Real Estate Equities, Inc. (ARE) was founded in 1994, pioneering the concept of life science real estate. It has grown significantly, focusing on developing and acquiring properties in innovation clusters.
Core Business Areas
- Life Science, AgriTech, and Technology Real Estate: Develops, owns, and operates properties for life science, agri-tech, and technology companies in key innovation clusters. Provides laboratory, office, and manufacturing space.
Leadership and Structure
The company is led by Joel S. Marcus (Executive Chairman and Founder). The organizational structure includes executive leadership overseeing various departments like real estate, finance, and legal.
Top Products and Market Share
Key Offerings
- Laboratory Space: Specialized laboratory facilities designed to meet the needs of life science and technology companies. ARE has significant market share in key innovation clusters, but specific figures fluctuate with regional market conditions and new developments. Competitors include BioMed Realty Trust, Boston Properties, and Healthpeak Properties.
- Office Space: Office spaces within their life science and tech campuses. Competitors include BioMed Realty Trust, Boston Properties, and Healthpeak Properties.
- Manufacturing Facilities: Specific manufacturing space to the Biotechnology industry. Competitors include BioMed Realty Trust, Boston Properties, and Healthpeak Properties.
Market Dynamics
Industry Overview
The life science real estate market is driven by research and development spending, venture capital funding, and demand for specialized facilities. It is competitive, with high barriers to entry due to the specialized nature of the space.
Positioning
Alexandria Real Estate Equities is a leading player in the life science real estate market, with a strong reputation and extensive portfolio in key innovation hubs. Its competitive advantage lies in its deep industry knowledge and relationships.
Total Addressable Market (TAM)
The TAM for life science real estate is estimated in the hundreds of billions of dollars globally, tied to biopharma R&D spending and infrastructure investment. ARE is well-positioned within key innovation clusters to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- Strong presence in key innovation clusters
- Deep industry expertise and relationships
- High-quality tenant base
- Proven track record of development and redevelopment
Weaknesses
- High concentration in specific geographic markets
- Exposure to economic cycles and fluctuations in R&D spending
- Dependence on key tenant relationships
Opportunities
- Expansion into new geographic markets
- Increased demand for specialized laboratory and manufacturing space
- Growth in the agri-tech sector
- Strategic acquisitions and partnerships
Threats
- Increased competition from other REITs and developers
- Economic downturns and reduced R&D spending
- Changes in government regulations
- Rising interest rates
Competitors and Market Share
Key Competitors
- BMR
- HCP
- SPG
Competitive Landscape
Alexandria Real Estate Equities benefits from its focus on life science, with many of its competitors being broad-based REITs.
Major Acquisitions
Seragon Biosciences
- Year: 2014
- Acquisition Price (USD millions): 730
- Strategic Rationale: Expanded ARE's presence in the San Diego life science cluster and added high-quality assets to its portfolio.
Growth Trajectory and Initiatives
Historical Growth: Alexandria Real Estate Equities has demonstrated consistent growth over the past decade, driven by acquisitions and development.
Future Projections: Analyst estimates project continued growth for Alexandria Real Estate Equities, driven by demand for life science real estate.
Recent Initiatives: Recent initiatives include expanding into new markets and focusing on sustainable development practices.
Summary
Alexandria Real Estate Equities is a strong player in the niche life science real estate market, leveraging its industry expertise and strategic location. However, it faces geographic concentration risks and is susceptible to changes in the biotech and pharmaceutical industries. The company benefits from increasing demand for specialized facilities but needs to manage competition and economic uncertainties. Their innovative approach is working well with what they need to look out for being interest rates
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, Market reports, Analyst estimates, News articles
Disclaimers:
This analysis is based on available information and assumptions. Actual results may vary. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alexandria Real Estate Equities Inc
Exchange NYSE | Headquaters Pasadena, CA, United States | ||
IPO Launch date 1997-05-27 | CEO & Chief Investment Officer Mr. Peter M. Moglia | ||
Sector Real Estate | Industry REIT - Office | Full time employees 552 | Website https://www.are.com |
Full time employees 552 | Website https://www.are.com | ||
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2025, Alexandria has a total market capitalization of $28.8 billion and an asset base in North America that includes 39.6 million RSF of operating properties and 4.0 million RSF of Class A/A+ properties undergoing construction. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.